Question 1

What is the catalog number for Tat-HA-NR2B9c?

Accepted Answer

The catalog number for Tat-HA-NR2B9c is orb1943727.

Question 2

What sizes are available for Tat-HA-NR2B9c?

Accepted Answer

Tat-HA-NR2B9c is available in the following size(s): 5 mg, 50 mg.

Question 3

How many pack sizes does Tat-HA-NR2B9c come in?

Accepted Answer

Tat-HA-NR2B9c is available in 2 different pack sizes.

Question 4

Is Tat-HA-NR2B9c in stock?

Accepted Answer

Tat-HA-NR2B9c is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What is Tat-HA-NR2B9c used for?

Accepted Answer

Tat-HA-NR2B9c is a fusion peptide containing an HIV-1 Tat fragment, an HA tag, and the NR2B9c sequence. It has been shown in rat models to reduce brain infarct volume and improve neurological outcomes after ischemic injury. This research tool is used to study neuroprotection and NMDA receptor signal

Question 6

Is this product classed as hazardous or restricted for shipping?

Accepted Answer

Some products are subject to special import/export regulations, dangerous goods handling, or licensing requirements. Where this applies, it’s noted on the product page, and any required extra documents or fees will be confirmed with you before dispatch, never added without your consent.

Question 7

Can you help me confirm if this product is right for my specific experiment?

Accepted Answer

Yes, contact us with details of your sample type, species, and intended application, and our specialists will confirm suitability or suggest an alternative from our supplier network if this isn’t the best fit.

Question 8

What is the purity of this recombinant protein?

Accepted Answer

Purity, typically assessed by SDS-PAGE, is listed on the datasheet under quality control data.

Tat-HA-NR2B9c

Product Specifications

Field of Research

Storage Conditions

Notes

Available Sizes

Frequently Asked Questions

Explore Other Products

Bcl-2 (100/D5 + 124), CF640R conjugate, 0.1mg/mL

TRIM29 (TRIM29/1041), 1mg/mL

Breast Tumor Kinase Antibody

Human CRTR1 (TFCP2L1) activation kit by CRISPRa

PAFAH1B3 Human Gene Knockout Kit (CRISPR)

TCF4 (Transcription Factor 4) (TCF4/1705), 0.2mg/mL